CNS Pharmaceuticals Inc CNSP

Healthcare Biotechnology

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's drug candidate, Berubicin, is the first anthracycline to appear to cross the blood-brain barrier. Berubicin is the subject of the Company's late-stage, fully-enrolled, global clinical trial for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. The Company's drug candidate, TPI 287, is an abeotaxane which stabilizes microtubules and inhibits cell division, causing apoptosis and cell death. TPI 287 has shown the potential to cross the blood-brain barrier and treat central nervous system (CNS) tumors.

NDAQ:CNSP - Post by User

CNS Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

(379)
•••

Post by Iseneschalon Apr 14, 2023 11:46am

61 Views

Post# 35395325

CNSP....... It's halted again

On the way up......and a volume spike to make it more interesting.

Hang on folks this is just the beginning.... IMHO !!!!

I told you all ..... Not to give up when it tanked a couple weeks ago ; )

I was buying this pig sub 70.... LoL

<< Previous

Bullboard Posts

Next >>

Carney's budget could lift this graphite stock higher